Company Frontier Biotechnologies Inc.

688221

CNE100005XF5

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 20/06/2024 BST			5-day change	1st Jan Change
6.59 ^CNY	+20.04%		+15.82%	-33.57%

04-25	Frontier Biotechnologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-23	Frontier Biotechnologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Frontier Biotechnologies Inc is a China-based company engaged in research and development, production and sales of innovative drugs. The Company's products include Aikening and Combination regiment of Albuvirtide (ABT) + 3BNC117 which is during clinical stage for treatment of human immunodeficiency virus (HIV). Its clinical-stage products also include transdermal analgesic patch AB001 for treating muscle, skeleton and joint pain. The Company conducts its businesses within the China market and to overseas markets.

Number of employees: 395

CNY in Million	2022	Weight	2023	Weight	Delta
Innovative Drugs 100.0 %	85	100.0 %	114	100.0 %	+34.82%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	85	100.0 %	114	100.0 %	+34.82%

Managers	Title	Age	Since
Rong Jian Lu FOU	Founder	62	14/01/13
Dong Xie FOU	Founder	58	14/01/13
Chang Jin Wang FOU	Founder	66	14/01/13
Qi Shao DFI	Director of Finance/CFO	44	30/11/15
Xiao Hong Zheng COO	Chief Operating Officer	62	28/02/19
Yu Ting Zhu ADM	Chief Administrative Officer	35	31/12/13
Li Na Bao IRC	Investor Relations Contact	-	31/07/16
Qian Ya Gao SEC	Corporate Secretary	38	28/02/19

Members of the board	Title	Age	Since
Chang Jin Wang FOU	Founder	66	14/01/13
Guang Ji Wang BRD	Director/Board Member	71	23/05/22
Yuan Tao Cao BRD	Director/Board Member	43	25/05/18
Dong Xie FOU	Founder	58	14/01/13
Chi Kit Ng BRD	Director/Board Member	51	09/02/19
Qian Ya Gao SEC	Corporate Secretary	38	28/02/19
Rong Jian Lu FOU	Founder	62	14/01/13
Kai Chen BRD	Director/Board Member	65	09/02/19
Zhi Zhong Jiang CHM	Chairman	42	30/06/14
Yu Ting Zhu ADM	Chief Administrative Officer	35	31/12/13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	374,578,653	194,665,953 ( 51.97 %)	0	51.97 %

Name	Equities	%	Valuation
Xiao Chen Zhang 5.169 %	10,633,104	5.169 %	9 M ¥
Beijing Ruifeng Investment Management Co. Ltd. 4.327 %	8,902,400	4.327 %	8 M ¥
UBS Asset Management Switzerland AG 2.250 %	4,629,271	2.250 %	4 M ¥
Quan Zhou 1.894 %	3,895,662	1.894 %	3 M ¥
Shenzhen Capital Group Co., Ltd. 1.543 %	3,173,400	1.543 %	3 M ¥
Guodu Venture Capital Co., Ltd. 1.439 %	2,960,769	1.439 %	3 M ¥
Wei Deng 1.351 %	2,778,696	1.351 %	2 M ¥
Gen Cai Yu 1.288 %	2,650,233	1.288 %	2 M ¥
Zhuhai Huajin Innovation Investment Co., Ltd. 1.215 %	2,500,000	1.215 %	2 M ¥
Hui Xie 1.159 %	2,383,423	1.159 %	2 M ¥

Name	Equities	%	Valuation
Dong Xie 67.30 %	113,636,250	67.30 %	100 M ¥
Rong Jian Lu 12.88 %	21,743,750	12.88 %	19 M ¥
Chang Jin Wang 12.47 %	21,059,500	12.47 %	19 M ¥
Deguang Tianjin Investment Partnership LP 3.503 %	5,915,000	3.503 %	5 M ¥
Jiezheng Investment Group Co. Ltd. 3.069 %	5,181,347	3.069 %	5 M ¥

Frontier Biotechnologies, Inc. (China)

11/F, Building E-2, Greenland Window Dongshan Street

211199, Nanjing

http://www.frontierbiotech.com

address Frontier Biotechnologies Inc.(688221)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
FRONTIER BIOTECHNOLOGIES INC.	-33.57%	340M
MERCK KGAA	+15.72%	77.46B
KYOWA KIRIN CO. LTD.	+13.65%	8.94B
SK BIOPHARMACEUTICALS CO., LTD.	-24.30%	4.28B
YUHAN CORPORATION	+12.79%	4.18B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+31.45%	4.11B
INDIVIOR PLC	+10.97%	2.23B
BETTA PHARMACEUTICALS CO., LTD.	-30.57%	2.06B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+8.99%	1.97B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-45.76%	1.69B

Specialty & Advanced Pharmaceuticals